排序方式: 共有3条查询结果,搜索用时 0 毫秒
1
1.
CORNELIO UDERZO MARIA GRAZIA VALSECCHI ADRIANA BALDUZZI GIORGIO DINI ROBERTO MINIERO FRANCO LOCATELLI ROBERTO RONDELLI ANDREA PESSION WILLIAM ARCESE ANDREA BACIGALUPO PAOLA POLCHI MARINO ANDOLINA CHIARA MESSINA VALENTINO CONTER MAURIZIO ARICÓ STEFANIA GALIMBERTI & GIUSEPPE MASERA 《British journal of haematology》1997,96(2):387-394
We compared the outcome of children with high-risk acute lymphoblastic leukaemia (HR-ALL) in first complete remission (first CR) treated with chemotherapy (CHEMO) or with allogeneic bone marrow transplantation (BMT) in a multicentre study. All children treated by the Italian Paediatric Haematology Oncology Association for HR-ALL in first CR between 1986 and 1994 were eligible for the study. 30 children were given BMT at a median of 4 months from first CR, with preparative regimens including total-body irradiation ( n =25/30). 130 matched controls for BMT patients were identified among 397 HR-ALL CHEMO patients. Matching on main prognostic factors and duration of first CR was adopted to control the selection and time-to-transplant biases. The comparative analysis was based on the results of a stratified Cox model. The estimated hazard ratios of BMT versus CHEMO at 6 months, 1 year and 2 years after CR were 1.38 (CI 0.59–3.24), 0.69 (CI 0.27–1.77) and 0.35 (CI 0.06–1{\raise 5mu ..91), with an overall non-significant difference between the two groups ( P = 0.34). With a median follow-up of 4 years, the disease-free survival was 58.5% (SE 9.3) in the BMT group and 47.7% (SE 4.8) in the CHEMO group, at 4 years from CR. Non-leukaemic death occurred in 4% of CHEMO and 10% of BMT patients. In the BMT group the estimated cumulative incidence of relapse at 1.5 years from CR was 31.5% (SE 8.8) and did not change thereafter, whereas in the CHEMO group the corresponding figure was 29.2% (SE 4.1) and the incidence continued to increase thereafter (48.2% (SE 4.8) at 4 years from CR). The results of this study suggest that, with respect to the CHEMO group, the higher risk of early failure in the BMT group is outweighed by the lower risk of relapse after 1 year. Results prompt the need for a prospective study, in order to demonstrate the likely advantage of BMT in HR childhood ALL in first CR. 相似文献
2.
Long-Term Follow-Up and Outcome of a Large Cohort of Patients with Common Variable Immunodeficiency 总被引:6,自引:0,他引:6
Quinti I Soresina A Spadaro G Martino S Donnanno S Agostini C Claudio P Franco D Maria Pesce A Borghese F Guerra A Rondelli R Plebani A;Italian Primary Immunodeficiency Network 《Journal of clinical immunology》2007,27(3):308-316
Common Variable Immunodeficiency belongs to the group of rare diseases encompassing antibody deficiency syndromes of highly
variable clinical presentation and outcome. The multicenter prospective study on a cohort of 224 patients with Common Variable
Immunodeficiency provides an updated view of the spectrum of illnesses which occurred at the clinical onset and over a long
period of follow-up (mean time: 11 years) and information on the effects of long-term immunoglobulin treatment. The mean age
at the time of diagnosis was 26.6 years. Seventy-five patients were younger than 14 years of age. The mean age at the onset
of symptoms was 16.9 years. This implicates with a mean diagnostic delay of 8.9 years. Respiratory tract infections were the
most prominent clinical problem observed at diagnosis and during the follow-up. Intravenous immunoglobulin administration
induced a significant reduction in the incidence of acute infections, mainly acute pneumonia and acute otitis. However, a
progressive increase in the prevalence of patients with chronic diseases, mainly sinusitis and lung disease, was observed
in all age groups, including the pediatric population. The morbidity of Common Variable Immunodeficiency due to all associated
clinical conditions increased over time despite an adequate replacement with intravenous immunoglobulins. Our data stressed
the need to develop international guidelines for the prevention and therapy of chronic lung disease, chronic sinusitis, chronic
diarrhoea, and chronic granulomatosis in patients with humoral immunodeficiencies.
WITHIN THE IPINET (Italian Primary Immunodeficiency Network) IPINET: De Mattia D, Martire B, Bari, Cossu F, Cagliari, Schirilló
G, Catania, Castagnola E, Genova, Pietrogrande MC, Delle Piane RM, Milano, Putti C, Padova, Trizzino A, Amato GM, Palermo,
Bertolini P, Parma, Zecca M, Pavia, Consolini R, Pisa, Moschese V, Rossi P, Cancrini C, Roma, Cazzola GA, Verona 相似文献
3.
G. P. BIANCHI G. MARCHESINI A. FABBRI A. RONDELLI E. BUGIANESI M. ZOLI E. PISI 《Journal of internal medicine》1993,233(5):385-392
Abstract. In a randomized cross-over comparison, the effects of a mainly vegetable protein diet were compared with an animal protein diet in eight patients with cirrhosis and chronic permanent encephalopathy, under optimum lactulose therapy. After a run-in period, patients were fed two equi-caloric, equi-nitrogenous diets for 7 days (71 g total proteins), containing either 50 g protein of animal origin or 50 g vegetable proteins. In the last 3 days of each period, nitrogen balance was significantly better during the vegetable protein diet (+ 0.2 (SD 1.4) g vs. — 1.7 (2.4): P < 0.01), the difference being entirely due to a reduced urinary nitrogen excretion. Average daytime integrated blood glucose was slightly higher during vegetable proteins, whereas insulin, plasma amino acids and ammonia were lower. The clinical grading of encephalopathy improved slightly on vegetable proteins, and psychometric tests improved significantly, but remained grossly abnormal. Compliance to dietary manipulation was good. The data prove that a mainly vegetable protein diet is worthwhile in cirrhotic patients with chronic encephalopathy under optimum lactulose therapy. Improved nitrogen balance may be related to more effective nitrogen use for protein synthesis, probably due to blunted hormonal response, and largely outweighs the effects on encephalopathy. 相似文献
1